Shalby Share Price Today

Shalby confirms Shanay Shah ceases as director after AGM rejection

Shalby Limited confirmed Mr. Shanay Vikram Shah ceased as Director and WTD on September 10, 2026. Shareholders rejected his appointment at the 22nd AGM with 81.71% voting against. Promoters abstained from voting, allowing public shareholders to decide the outcome. Mr. Shah will continue to serve as President of the Company despite the rejection. Financial statements and cost auditor remuneration were approved with overwhelming support.

Shalby AGM on Sep 10: Shanay Shah proposed as Whole-Time Director

Shalby Limited convenes its 22nd AGM on September 10, 2026, primarily to approve the appointment of Shanay Vikram Shah as Whole-Time Director for five years. The related-party transaction involves a maximum annual remuneration of ₹1.50 crore. Shareholders can vote electronically via NSDL between September 5 and September 9, 2026.

Shalby releases Q1 FY27 earnings call transcript with management commentary

Shalby Limited disclosed its Q1 FY27 earnings call transcript on August 19, 2026. The filing details consolidated revenue of ₹338.6 crore and PAT of ₹10.5 crore. Management emphasized improved hospital occupancy rates and the first-time EBITDA break-even at the Gurgaon unit, signaling operational stabilization across key segments.

Shalby Medtech CEO Deepak Anand resigns to move abroad

Deepak Anand resigns as CEO of Shalby Medtech Limited, a subsidiary of Shalby Limited, effective September 4, 2026. He cited personal reasons for moving abroad as the sole cause for his exit. Shalby Limited confirmed no other material factors influenced the decision.

Shalby files BRSR for FY26; energy intensity drops 18%

Shalby Limited’s FY26 BRSR reveals a 16.75% drop in non-renewable electricity use and an 18.4% improvement in energy intensity. Fuel consumption rose 43.45% due to higher generator usage. CSR spending reached ₹32.18 million.

Shalby Q1 Results: Consolidated net profit rises 37% YoY to ₹105 crore

Shalby Limited delivered strong consolidated results for Q1FY27, with net profit jumping 37% YoY to ₹104.96 million on the back of 11.7% revenue growth. However, standalone net profit edged down 2.4% to ₹250.66 million, indicating margin pressures in the core hospital business despite higher operational income. The results were approved by the Board on August 12, 2026.